Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again

Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again·Investor's Business Daily
In this article:

Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.

Advertisement